AI Ethics & Society · AI and Mental Health Risks

Are AI companies studying the mental health effects of their products?

Some major AI companies have begun publicly acknowledging mental health concerns and funding or publishing limited research and safety measures, but independent researchers argue this internal study is uneven, often reactive to public pressure, and not as rigorous or transparent as research into effects of other consumer technologies.

Medical disclaimer

This page is for general educational purposes only and is not medical advice. It does not replace a consultation with a licensed physician, pharmacist, or other qualified health provider. Always talk to your own care team before starting, stopping, or changing any medication or supplement.

Key takeaways

Several AI companies have publicly acknowledged mental health risks tied to their products, particularly around companion and chatbot use.
Some companies have introduced features like usage break reminders or crisis-resource referrals, suggesting internal awareness of the issue.
Independent researchers and critics argue that much of this work is reactive, occurring after public or media scrutiny rather than proactively.
Companies generally have far more internal usage data than outside researchers, but they don't always share it, limiting independent verification of internal findings.
The level of rigor and transparency in this research varies significantly across companies and products.

A Mixed and Evolving Picture

Whether AI companies are seriously studying the mental health effects of their products depends significantly on which company and product you’re looking at. In recent years, as concerns about chatbot and companion app use have drawn more public and media attention, several major AI companies have publicly acknowledged that mental health is a relevant consideration in how they design and deploy their products. Some have introduced features intended to address specific concerns, such as reminders to take breaks during long conversations or referrals to crisis resources when a conversation suggests a user may be in distress.

At the same time, independent researchers, journalists, and mental health advocates have raised concerns that this internal work is often uneven — more developed at some companies than others, and frequently introduced only after public scrutiny rather than as a proactive, built-in part of product development from the start.

Reactive Versus Proactive Research

A recurring critique from outside observers is that visible safety measures often appear to follow negative press coverage, public incidents, or advocacy pressure, rather than preceding product launches as a standard part of the development process. This pattern — sometimes described as reactive rather than proactive — leads some critics to question how much rigorous internal research occurs before a product reaches a large user base, as opposed to after problems have already become public.

It’s worth noting that AI companies are not unique in facing this critique; similar patterns have been observed in other consumer technology sectors, including social media, where internal research on mental health effects has sometimes only become public through leaks, lawsuits, or regulatory investigations rather than voluntary disclosure.

The Transparency Gap

AI companies generally have access to far more granular data about how people actually use their products than outside researchers do — including patterns of use, conversation content (subject to privacy protections), and engagement metrics. This creates a significant information asymmetry: companies are often best positioned to detect early signs of problematic use patterns, but they don’t always share this data or their internal findings with independent researchers, regulators, or the public. Some companies have taken steps toward greater transparency, such as publishing safety reports or partnering with outside researchers, but this remains inconsistent across the industry, and independent verification of internal claims remains difficult without greater data access.

Bottom Line

Some AI companies are studying and publicly addressing the mental health effects of their products, particularly through safety features and occasional research disclosures, but critics argue this work is often reactive to public pressure rather than proactive, and limited transparency around internal data makes it difficult for outside researchers to independently verify how thoroughly companies are studying these effects.

Go deeper

Important caveats

This is a fast-moving area; specific company practices and disclosures can change and should be verified against current statements.

Frequently asked questions

Do AI companies share their internal mental health research publicly?

Practices vary widely. Some companies have published blog posts, safety reports, or academic collaborations addressing mental health considerations, while much of what companies know from internal usage data and testing is not made fully public, limiting outside researchers' ability to independently verify claims.

Why would an AI company be reluctant to publish findings about mental health risks in its own products?

Companies face competing incentives: publishing findings that suggest their product carries risks could invite regulatory scrutiny, reputational harm, or legal liability, which some critics argue creates a disincentive for full transparency, even when companies say they take user wellbeing seriously.

Have any AI companies partnered with outside mental health experts or institutions?

Some companies have engaged with outside clinicians, researchers, or advisory groups on safety-related features, particularly following public incidents or criticism, though the extent and independence of these collaborations vary by company.

Sources

[1]World Economic Forum — World Economic Forum
[2]Pew Research Center: Internet & Technology — Pew Research Center

Written by Editorial Team

Last updated July 25, 2026

Get one well-sourced answer a week

No spam. Unsubscribe anytime.